Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,580 | 48,534 | 53,407 | 45,728 | 56,746 |
| Marketable Securities | 114,375 | 88,609 | 54,972 | 31,371 | 20,575 |
| Receivables | 51,763 | 45,925 | 39,907 | 41,547 | 41,615 |
| Inventories | 11,506 | 13,303 | 10,423 | 4,659 | 6,002 |
| TOTAL | $240,166 | $214,927 | $175,393 | $146,563 | $135,103 |
| Non-Current Assets | |||||
| PPE Net | N/A | 54 | 57 | 76 | N/A |
| Intangibles | 24,748 | 25,336 | 25,924 | 26,512 | 27,100 |
| Other Non-Current Assets | 248,680 | 2,217 | 5,362 | 2,821 | 1,773 |
| TOTAL | $273,428 | $27,607 | $31,343 | $29,409 | $28,873 |
| Total Assets | $513,594 | $242,534 | $206,736 | $175,972 | $163,976 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,191 | 3,846 | 7,290 | 3,954 | 3,339 |
| Accrued Expenses | 17,438 | 14,881 | 12,018 | 10,672 | 14,212 |
| Other current liabilities | 44,182 | 35,020 | 34,502 | 27,935 | 38,191 |
| TOTAL | $99,237 | $94,400 | $86,636 | $66,629 | $63,299 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,482 | 29,969 | 37,452 | 44,931 | 52,408 |
| Deferred Revenues | N/A | 1,355 | 1,355 | 1,355 | N/A |
| Other Non-Current Liabilities | 395 | 556 | 714 | 45,845 | 44,981 |
| TOTAL | $22,877 | $30,525 | $38,166 | $90,776 | $97,389 |
| Total Liabilities | $122,114 | $124,925 | $124,802 | $157,405 | $160,688 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,473 | 18,151 | 17,937 | 17,872 | 17,863 |
| Common Shares | 18 | 18 | 18 | 18 | 18 |
| Retained earnings | -1,023,041 | -1,291,106 | -1,319,006 | -1,378,619 | -1,390,065 |
| Other shareholders' equity | 181 | 96 | 6 | -2 | 10 |
| TOTAL | $391,480 | $117,609 | $81,934 | $18,567 | $3,288 |
| Total Liabilities And Equity | $513,594 | $242,534 | $206,736 | $175,972 | $163,976 |